ABOUT CEFTRIAXONE API - 104376-79-6

C. difficile makes toxins A and B which contribute to the development of CDAD. Hypertoxin making strains of C. difficile lead to increased morbidity and mortality, as these infections might be refractory to antimicrobial therapy and may call for colectomy.Microbiology The bactericidal activity of ceftriaxone outcomes from inhibition of mobile wall